2021 Q2 Form 10-Q Financial Statement

#000088559021000041 Filed on August 03, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $2.100B $1.664B
YoY Change 26.2% -22.68%
Cost Of Revenue $612.0M $495.0M
YoY Change 23.64% -16.67%
Gross Profit $1.488B $1.169B
YoY Change 27.29% -24.97%
Gross Profit Margin 70.86% 70.25%
Selling, General & Admin $685.0M $526.0M
YoY Change 30.23% -19.2%
% of Gross Profit 46.03% 45.0%
Research & Development $115.0M $108.0M
YoY Change 6.48% -7.69%
% of Gross Profit 7.73% 9.24%
Depreciation & Amortization $404.0M $480.0M
YoY Change -15.83% -9.6%
% of Gross Profit 27.15% 41.06%
Operating Expenses $800.0M $634.0M
YoY Change 26.18% -17.45%
Operating Profit -$270.0M -$27.00M
YoY Change 900.0% -110.51%
Interest Expense -$355.0M -$383.0M
YoY Change -7.31% -4.96%
% of Operating Profit
Other Income/Expense, Net -$542.0M -$118.0M
YoY Change 359.32% 1375.0%
Pretax Income -$670.0M -$437.0M
YoY Change 53.32% 144.13%
Income Tax -$77.00M -$112.0M
% Of Pretax Income
Net Earnings -$595.0M -$326.0M
YoY Change 82.52% 91.76%
Net Earnings / Revenue -28.33% -19.59%
Basic Earnings Per Share -$1.66 -$0.92
Diluted Earnings Per Share -$1.66 -$0.92
COMMON SHARES
Basic Shares Outstanding 359.1M shares 355.3M shares
Diluted Shares Outstanding 359.1M shares 355.3M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $642.0M $896.0M
YoY Change -28.35% 2.05%
Cash & Equivalents $642.0M $896.0M
Short-Term Investments
Other Short-Term Assets $2.113B $1.787B
YoY Change 18.24% 155.29%
Inventory $1.086B $1.226B
Prepaid Expenses
Receivables $1.609B $1.369B
Other Receivables $0.00 $0.00
Total Short-Term Assets $5.450B $5.278B
YoY Change 3.26% 18.16%
LONG-TERM ASSETS
Property, Plant & Equipment $1.590B $1.496B
YoY Change 6.28% 9.04%
Goodwill $12.53B $13.08B
YoY Change -4.26% -0.58%
Intangibles $7.624B $9.297B
YoY Change -18.0% -16.96%
Long-Term Investments
YoY Change
Other Assets $596.0M $367.0M
YoY Change 62.4% 1.94%
Total Long-Term Assets $24.59B $26.12B
YoY Change -5.84% -6.34%
TOTAL ASSETS
Total Short-Term Assets $5.450B $5.278B
Total Long-Term Assets $24.59B $26.12B
Total Assets $30.04B $31.40B
YoY Change -4.31% -2.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $442.0M $447.0M
YoY Change -1.12% -15.18%
Accrued Expenses $5.075B $4.270B
YoY Change 18.85% 36.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $1.000M
YoY Change -100.0% -98.21%
Total Short-Term Liabilities $5.517B $4.718B
YoY Change 16.94% 27.34%
LONG-TERM LIABILITIES
Long-Term Debt $23.44B $24.36B
YoY Change -3.77% 1.39%
Other Long-Term Liabilities $975.0M $802.0M
YoY Change 21.57% 2.43%
Total Long-Term Liabilities $24.41B $25.16B
YoY Change -2.96% 1.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.517B $4.718B
Total Long-Term Liabilities $24.41B $25.16B
Total Liabilities $30.65B $30.85B
YoY Change -0.64% 3.99%
SHAREHOLDERS EQUITY
Retained Earnings -$9.218B -$7.931B
YoY Change 16.23% 34.72%
Common Stock $10.71B $10.63B
YoY Change 0.8% 0.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$687.0M $474.0M
YoY Change
Total Liabilities & Shareholders Equity $30.04B $31.40B
YoY Change -4.31% -2.96%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$595.0M -$326.0M
YoY Change 82.52% 91.76%
Depreciation, Depletion And Amortization $404.0M $480.0M
YoY Change -15.83% -9.6%
Cash From Operating Activities $395.0M $200.0M
YoY Change 97.5% -41.0%
INVESTING ACTIVITIES
Capital Expenditures -$64.00M -$71.00M
YoY Change -9.86% 12.7%
Acquisitions
YoY Change
Other Investing Activities $21.00M $4.000M
YoY Change 425.0% -20.0%
Cash From Investing Activities -$43.00M -$67.00M
YoY Change -35.82% 15.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -388.0M -153.0M
YoY Change 153.59% -18.62%
NET CHANGE
Cash From Operating Activities 395.0M $200.0M
Cash From Investing Activities -43.00M -67.00M
Cash From Financing Activities -388.0M -153.0M
Net Change In Cash -36.00M $200.0M
YoY Change -118.0% -41.0%
FREE CASH FLOW
Cash From Operating Activities $395.0M $200.0M
Capital Expenditures -$64.00M -$71.00M
Free Cash Flow $459.0M $271.0M
YoY Change 69.37% -32.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000885590
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2020Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-14956
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
358808755 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
642000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
605000000 USD
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1214000000 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1211000000 USD
CY2021Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
1609000000 USD
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
1577000000 USD
CY2021Q2 us-gaap Inventory Net
InventoryNet
1086000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1094000000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
899000000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
855000000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
5450000000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
5342000000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1590000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1567000000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7624000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8445000000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
12527000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
13044000000 USD
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2255000000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2137000000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
596000000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
664000000 USD
CY2021Q2 us-gaap Assets
Assets
30042000000 USD
CY2020Q4 us-gaap Assets
Assets
31199000000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
442000000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
337000000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5075000000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4576000000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5517000000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4913000000 USD
CY2021Q2 bhc Business Combination Contingent Consideration Noncurrent Liability
BusinessCombinationContingentConsiderationNoncurrentLiability
206000000 USD
CY2020Q4 bhc Business Combination Contingent Consideration Noncurrent Liability
BusinessCombinationContingentConsiderationNoncurrentLiability
216000000 USD
dei City Area Code
CityAreaCode
514
dei Local Phone Number
LocalPhoneNumber
744-6792
dei Entity Registrant Name
EntityRegistrantName
Bausch Health Companies Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0448205
dei Entity Address Address Line1
EntityAddressAddressLine1
2150 St. Elzéar Blvd. West
dei Entity Address City Or Town
EntityAddressCityOrTown
Laval
dei Entity Address State Or Province
EntityAddressStateOrProvince
QC
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
H7L 4A8
dei Security12b Title
Security12bTitle
Common Shares, No Par Value
dei Trading Symbol
TradingSymbol
BHC
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23439000000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23925000000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
516000000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
528000000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
975000000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1012000000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
30653000000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
30594000000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
358653899 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
358653899 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
355422347 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
355422347 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
10300000000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
10227000000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
413000000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
454000000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9218000000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8013000000 USD
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2182000000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2133000000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-687000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
535000000 USD
CY2021Q2 us-gaap Minority Interest
MinorityInterest
76000000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
70000000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-611000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
605000000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30042000000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31199000000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2100000000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1664000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4127000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3676000000 USD
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
685000000 USD
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
526000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1291000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1159000000 USD
CY2021Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
115000000 USD
CY2020Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
108000000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
227000000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
230000000 USD
CY2021Q2 bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
360000000 USD
CY2020Q2 bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
436000000 USD
bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
717000000 USD
bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
872000000 USD
CY2021Q2 bhc Goodwill Impairment Loss Not Included In Asset Impairment Charges
GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges
0 USD
CY2020Q2 bhc Goodwill Impairment Loss Not Included In Asset Impairment Charges
GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges
0 USD
bhc Goodwill Impairment Loss Not Included In Asset Impairment Charges
GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges
469000000 USD
bhc Goodwill Impairment Loss Not Included In Asset Impairment Charges
GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges
0 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
47000000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1000000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
195000000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
15000000 USD
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
9000000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
7000000 USD
us-gaap Restructuring Charges
RestructuringCharges
21000000 USD
us-gaap Restructuring Charges
RestructuringCharges
11000000 USD
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-542000000 USD
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-118000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-512000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-154000000 USD
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
2370000000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
1691000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
4618000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
3455000000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-270000000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-491000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
221000000 USD
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
4000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
9000000 USD
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
364000000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
385000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
732000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
781000000 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-45000000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-27000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-50000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-51000000 USD
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7000000 USD
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
8000000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-13000000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-670000000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-437000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1261000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-615000000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-77000000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-112000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-61000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-138000000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-593000000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-325000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5000000 USD
us-gaap Profit Loss
ProfitLoss
-1200000000 USD
us-gaap Profit Loss
ProfitLoss
-477000000 USD
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-595000000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-326000000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1205000000 USD
us-gaap Net Income Loss
NetIncomeLoss
-478000000 USD
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.92
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.35
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
359100000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
359100000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
355300000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
355300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
358000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
358000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
354300000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
354300000 shares
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-593000000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-325000000 USD
us-gaap Profit Loss
ProfitLoss
-1200000000 USD
us-gaap Profit Loss
ProfitLoss
-477000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
76000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
54000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-48000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-138000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
1000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-4000000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
1000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
75000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
58000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-48000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-139000000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-518000000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-267000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1248000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-616000000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
3000000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
6000000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-521000000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-268000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1254000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-615000000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-124000000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4000000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31000000 USD
CY2021Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
4000000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-593000000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
75000000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-611000000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
790000000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27000000 USD
CY2020Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
5000000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-325000000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
58000000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
546000000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
605000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62000000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
45000000 USD
us-gaap Profit Loss
ProfitLoss
-1200000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-48000000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-611000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1136000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2000000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54000000 USD
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
29000000 USD
us-gaap Profit Loss
ProfitLoss
-477000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-139000000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
546000000 USD
us-gaap Profit Loss
ProfitLoss
-1200000000 USD
us-gaap Profit Loss
ProfitLoss
-477000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
807000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
961000000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
25000000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
32000000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
195000000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
15000000 USD
bhc Goodwill Impairment Loss Not Included In Asset Impairment Charges
GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges
469000000 USD
bhc Goodwill Impairment Loss Not Included In Asset Impairment Charges
GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges
0 USD
bhc Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
0 USD
bhc Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
24000000 USD
bhc Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
35000000 USD
bhc Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
34000000 USD
bhc Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-120000000 USD
bhc Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
-194000000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
23000000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1000000 USD
bhc Gain Loss Related To Litigation Settlement Gross
GainLossRelatedToLitigationSettlementGross
-532000000 USD
bhc Gain Loss Related To Litigation Settlement Gross
GainLossRelatedToLitigationSettlementGross
-143000000 USD
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
129000000 USD
us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
34000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
62000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
54000000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-7000000 USD
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-11000000 USD
bhc Derivative Gain Excluded Component
DerivativeGainExcludedComponent
11000000 USD
bhc Derivative Gain Excluded Component
DerivativeGainExcludedComponent
11000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-50000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-51000000 USD
bhc Payment For Contingent Consideration Liability Including Accretion Operating Activities
PaymentForContingentConsiderationLiabilityIncludingAccretionOperatingActivities
8000000 USD
bhc Payment For Contingent Consideration Liability Including Accretion Operating Activities
PaymentForContingentConsiderationLiabilityIncludingAccretionOperatingActivities
1000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
24000000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
9000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
48000000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-423000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
47000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
188000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-21000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
245000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-356000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
838000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
461000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
128000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
141000000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4000000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
11000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
8000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6000000 USD
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
25000000 USD
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
21000000 USD
bhc Interest Settlement On Cross Currency Swaps
InterestSettlementOnCrossCurrencySwaps
11000000 USD
bhc Interest Settlement On Cross Currency Swaps
InterestSettlementOnCrossCurrencySwaps
11000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-107000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1579000000 USD
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1477000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2100000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3062000000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
1000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
45000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
29000000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
41000000 USD
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
23000000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
38000000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
39000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1337000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1816000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3244000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
14000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
1000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-631000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1674000000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6000000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-17000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
102000000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1918000000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1907000000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
642000000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
896000000 USD
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1214000000 USD
CY2020Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
1011000000 USD
CY2021Q2 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
62000000 USD
CY2020Q2 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
0 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1918000000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1907000000 USD
us-gaap Nature Of Operations
NatureOfOperations
DESCRIPTION OF BUSINESS Bausch Health Companies Inc. (the “Company” or "Bausch Health") is a multinational, specialty pharmaceutical and medical device company that develops, manufactures and markets, primarily in the therapeutic areas of eye health, gastroenterology ("GI") and dermatology, a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (“OTC”) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices) which are marketed directly or indirectly in approximately 100 countries.
CY2021Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
100 country
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the unaudited Consolidated Financial Statements, management is required to make estimates and assumptions. This includes estimates and assumptions regarding the nature, timing and extent of the impacts that the COVID-19 pandemic will have on its operations and cash flows. The estimates and assumptions used by the Company affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited Consolidated Financial Statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates and the differences could be material. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s results of operations and financial position could be materially impacted.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation.</span></div>
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1813000000 USD
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
2713000000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
2546000000 USD
CY2021Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1980000000 USD
CY2019Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
2050000000 USD
us-gaap Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
2377000000 USD
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
2586000000 USD
CY2020Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1841000000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
39000000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
48000000 USD
bhc Accounts Receivable Effect Of Retrospective Application Of Accounting Standards Update
AccountsReceivableEffectOfRetrospectiveApplicationOfAccountingStandardsUpdate
0 USD
bhc Accounts Receivable Effect Of Retrospective Application Of Accounting Standards Update
AccountsReceivableEffectOfRetrospectiveApplicationOfAccountingStandardsUpdate
1000000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6000000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1000000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
2000000 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
1000000 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
1000000 USD
bhc Accounts Receivable Allowance For Foreign Exchange And Other
AccountsReceivableAllowanceForForeignExchangeAndOther
0 USD
bhc Accounts Receivable Allowance For Foreign Exchange And Other
AccountsReceivableAllowanceForForeignExchangeAndOther
2000000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
39000000 USD
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
52000000 USD
CY2021Q2 us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
10000000 USD
CY2021Q2 bhc Additional Payments To Acquire Equity Securities Fvni Expected
AdditionalPaymentsToAcquireEquitySecuritiesFVNIExpected
0 USD
bhc Highly Liquid Investments Maturity Period
HighlyLiquidInvestmentsMaturityPeriod
P3M
us-gaap Payments For Proceeds From Hedge Investing Activities
PaymentsForProceedsFromHedgeInvestingActivities
11000000 USD
us-gaap Payments For Proceeds From Hedge Investing Activities
PaymentsForProceedsFromHedgeInvestingActivities
11000000 USD
CY2021Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
7000000 USD
CY2020Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
4000000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
5000000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
0 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
24000000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
49000000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-1000000 USD
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
328000000 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
316000000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
24000000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
1000000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Other Comprehensive Income
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome
0 USD
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
280000000 USD
CY2020Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
316000000 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
74000000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
37000000 USD
CY2021Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
206000000 USD
CY2020Q2 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
279000000 USD
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
293000000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
286000000 USD
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
123000000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
143000000 USD
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
670000000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
665000000 USD
CY2021Q2 us-gaap Inventory Gross
InventoryGross
1086000000 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
1094000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
25471000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19552000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5919000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
25481000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18741000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6740000000 USD
CY2021Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
27176000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19552000000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7624000000 USD
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
27186000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
18741000000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8445000000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
195000000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
15000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
660000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
1176000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1019000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
896000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
812000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
679000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
677000000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5919000000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
13126000000 USD
CY2020 bhc Goodwill Transfers Related To Sale Of Business Unit
GoodwillTransfersRelatedToSaleOfBusinessUnit
18000000 USD
CY2020 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
217000000 USD
CY2020 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-117000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
13044000000 USD
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
469000000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
48000000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
12527000000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2100000000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1664000000 USD
CY2021Q2 bhc Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax
IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTax
436000000 USD
CY2020Q2 bhc Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax Percentage
IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTaxPercentage
-0.23
CY2020Q3 bhc Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax Percentage
IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTaxPercentage
-0.03
CY2020Q4 bhc Increase Decrease In Year Over Year Revenue From Contract With Customer Excluding Assessed Tax Percentage
IncreaseDecreaseInYearOverYearRevenueFromContractWithCustomerExcludingAssessedTaxPercentage
-0.01
CY2021Q1 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.40
CY2021Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q2 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.45
CY2021Q2 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.45
CY2021Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q2 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
4180000000 USD
CY2021Q2 bhc Legalsettlementsandrelatedfees
Legalsettlementsandrelatedfees
2076000000 USD
CY2020Q4 bhc Legalsettlementsandrelatedfees
Legalsettlementsandrelatedfees
1672000000 USD
CY2021Q2 bhc Accrued Product Rebate Current
AccruedProductRebateCurrent
940000000 USD
CY2020Q4 bhc Accrued Product Rebate Current
AccruedProductRebateCurrent
747000000 USD
CY2021Q2 bhc Accrued Product Return Current
AccruedProductReturnCurrent
533000000 USD
CY2020Q4 bhc Accrued Product Return Current
AccruedProductReturnCurrent
575000000 USD
CY2021Q2 us-gaap Interest Payable Current
InterestPayableCurrent
353000000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
341000000 USD
CY2021Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
292000000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-27000000 USD
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
316000000 USD
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
110000000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
158000000 USD
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
771000000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
767000000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5075000000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4576000000 USD
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
23685000000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
23439000000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
24185000000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
23925000000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23439000000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23925000000 USD
bhc Debt Instrument Redemption Price Percentage Changein Control
DebtInstrumentRedemptionPricePercentageChangeinControl
1.01
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-38000000 USD
CY2021Q2 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0585
CY2020Q4 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0602
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
0 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
291000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
10532000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1500000000 USD
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
11362000000 USD
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
23685000000 USD
CY2021Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
246000000 USD
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
23439000000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31000000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
62000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
54000000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31000000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
62000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
54000000 USD
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
169000000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M18D
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0 USD
CY2021Q2 bhc Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
109000000 USD
CY2020Q2 bhc Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
100000000 USD
bhc Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
214000000 USD
bhc Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
214000000 USD
CY2021Q2 bhc Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
6000000 USD
CY2020Q2 bhc Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
8000000 USD
bhc Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
13000000 USD
bhc Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
16000000 USD
CY2021Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
115000000 USD
CY2020Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
108000000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
227000000 USD
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
230000000 USD
CY2021Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-532000000 USD
CY2020Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-100000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-532000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-123000000 USD
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
9000000 USD
CY2020Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
11000000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
24000000 USD
CY2021Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2020Q2 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
23000000 USD
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1000000 USD
CY2021Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
1000000 USD
CY2020Q2 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
7000000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
3000000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
8000000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-542000000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-118000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-512000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-154000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-61000000 USD
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-50000000 USD
bhc Effective Income Tax Rate Reconciliation Discrete Items Amount
EffectiveIncomeTaxRateReconciliationDiscreteItemsAmount
-11000000 USD
bhc Effective Income Tax Rate Reconciliation Legal Settlements Amount
EffectiveIncomeTaxRateReconciliationLegalSettlementsAmount
-54000000 USD
bhc Effective Income Tax Rate Reconciliation Withholding Tax Intercompany Dividends Amount
EffectiveIncomeTaxRateReconciliationWithholdingTaxIntercompanyDividendsAmount
46000000 USD
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-7000000 USD
bhc Effective Income Tax Rate Reconciliation Expense Filing Tax Returns Amount
EffectiveIncomeTaxRateReconciliationExpenseFilingTaxReturnsAmount
4000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-138000000 USD
bhc Effective Income Tax Rate Reconciliation Discrete Items Amount
EffectiveIncomeTaxRateReconciliationDiscreteItemsAmount
-99000000 USD
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-64000000 USD
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-39000000 USD
us-gaap Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
-12000000 USD
us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-17000000 USD
us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-4000000 USD
bhc Effective Income Tax Rate Reconciliation Expense Filing Tax Returns Amount
EffectiveIncomeTaxRateReconciliationExpenseFilingTaxReturnsAmount
2000000 USD
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2272000000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2252000000 USD
CY2021Q2 bhc Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
1118000000 USD
CY2020Q4 bhc Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
1025000000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
52000000 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
49000000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
542000000 USD
CY2021Q2 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
198000000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-595000000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-326000000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1205000000 USD
us-gaap Net Income Loss
NetIncomeLoss
-478000000 USD
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
359100000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
359100000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
355300000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
355300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
358000000.0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
358000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
354300000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
354300000 shares
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.92
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.35
CY2021Q2 us-gaap Litigation Reserve Current
LitigationReserveCurrent
2076000000 USD
CY2021Q2 bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
360000000 USD
CY2020Q2 bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
436000000 USD
bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
717000000 USD
bhc Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
872000000 USD
CY2021Q2 bhc Goodwill Impairment Loss Not Included In Asset Impairment Charges
GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges
0 USD
CY2020Q2 bhc Goodwill Impairment Loss Not Included In Asset Impairment Charges
GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges
0 USD
bhc Goodwill Impairment Loss Not Included In Asset Impairment Charges
GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges
469000000 USD
bhc Goodwill Impairment Loss Not Included In Asset Impairment Charges
GoodwillImpairmentLossNotIncludedInAssetImpairmentCharges
0 USD
CY2021Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
47000000 USD
CY2020Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1000000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
195000000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
15000000 USD
CY2021Q2 us-gaap Restructuring Charges
RestructuringCharges
9000000 USD
CY2020Q2 us-gaap Restructuring Charges
RestructuringCharges
7000000 USD
us-gaap Restructuring Charges
RestructuringCharges
21000000 USD
us-gaap Restructuring Charges
RestructuringCharges
11000000 USD
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-542000000 USD
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-118000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-512000000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-154000000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-270000000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-491000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
221000000 USD
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
4000000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
9000000 USD
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
364000000 USD
CY2020Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
385000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
732000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
781000000 USD
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-45000000 USD
CY2020Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-27000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-50000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-51000000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2100000000 USD
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7000000 USD
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
8000000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-13000000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-670000000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-437000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1261000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-615000000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1664000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4127000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3676000000 USD
bhc Concentration Risk Number Of Products
ConcentrationRiskNumberOfProducts
10 product
bhc Concentration Risk Number Of Products
ConcentrationRiskNumberOfProducts
10 product
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2100000000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1664000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4127000000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3676000000 USD

Files In Submission

Name View Source Status
0000885590-21-000041-index-headers.html Edgar Link pending
0000885590-21-000041-index.html Edgar Link pending
0000885590-21-000041.txt Edgar Link pending
0000885590-21-000041-xbrl.zip Edgar Link pending
bhc-20210630.htm Edgar Link pending
bhc-20210630.xsd Edgar Link pending
bhc-20210630_cal.xml Edgar Link unprocessable
bhc-20210630_def.xml Edgar Link unprocessable
bhc-20210630_htm.xml Edgar Link completed
bhc-20210630_lab.xml Edgar Link unprocessable
bhc-20210630_pre.xml Edgar Link unprocessable
exhibit101q22021.htm Edgar Link pending
exhibit311q22021.htm Edgar Link pending
exhibit312q22021.htm Edgar Link pending
exhibit321q22021.htm Edgar Link pending
exhibit322q22021.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending